Work

Efficacy and Safety of Bosutinib Vs Imatinib By Charlson Comorbidity Index in Newly Diagnosed Patients with Chronic Myeloid Leukemia

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-163276

Authors: Michael W. Deininger, Tim H Brummendorf, Jeffrey H. Lipton, Dragana Milojkovic, Leif Stenke, Eric Leip, Simon Purcell, Andrea Viqueira, Jorge E. Cortes

Institutions: University of Utah, Huntsman Cancer Institute, Universitätsklinikum Aachen, RWTH Aachen University, Princess Margaret Cancer Centre, Hammersmith Hospital, Karolinska University Hospital, Karolinska Institutet, Pfizer (Spain), Augusta University

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310125632

FWCI:

Cites:

Cited by:

Related to: 10